{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:12:59Z","timestamp":1790734379686,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008065","name":"Georgia Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA138292"],"award-info":[{"award-number":["P30CA138292"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011621","name":"Emory University Winship Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jbc.2025.111127","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:06:30Z","timestamp":1767139590000},"page":"111127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification and characterization of vasoactive intestinal peptide receptor antagonists with high-affinity and potent anti-leukemia activity"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8675-8055","authenticated-orcid":false,"given":"Yuou","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Sen-Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srijon","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3393-8161","authenticated-orcid":false,"given":"Tenzin","family":"Passang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2058-7684","authenticated-orcid":false,"given":"Sonia","family":"Mecorapaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapnaa","family":"Balaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3790-310X","authenticated-orcid":false,"given":"Tenzin","family":"Kalsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio B.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiranj","family":"Chaudagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankoj Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabute","family":"Bruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Papadantonakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia R.","family":"Giver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0816-6729","authenticated-orcid":false,"given":"Edmund K.","family":"Waller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.111127_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0304-3940(77)90073-8","article-title":"Vasoactive intestinal polypeptide and the nervous system: immunohistochemical evidence for localization in central and peripheral neurons, particularly intracortical neurons of the cerebral cortex","volume":"5","author":"Fuxe","year":"1977","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jbc.2025.111127_bib2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1126\/science.1273576","article-title":"Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissue","volume":"192","author":"Said","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.jbc.2025.111127_bib3","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/MPA.0000000000001402","article-title":"Vasoactive intestinal peptide\u2013secreting tumors","volume":"48","author":"Siddappa","year":"2019","journal-title":"Pancreas"},{"key":"10.1016\/j.jbc.2025.111127_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1476-5381.2012.01871.x","article-title":"Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1","volume":"166","author":"Harmar","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jbc.2025.111127_bib5","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1038\/s41467-022-34242-4","article-title":"Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma","volume":"13","author":"Ravindranathan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.111127_bib6","first-page":"1217","article-title":"Polypeptide with broad biological activity: isolation from small intestine","volume":"169","author":"Said","year":"1970","journal-title":"Science (1979)"},{"key":"10.1016\/j.jbc.2025.111127_bib7","doi-asserted-by":"crossref","first-page":"G16","DOI":"10.1152\/ajpgi.00081.2017","article-title":"Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine","volume":"313","author":"Jayawardena","year":"2017","journal-title":"Am. J. Physiol. Gastrointest. Liver. Physiol."},{"key":"10.1016\/j.jbc.2025.111127_bib8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-020-2039-9","article-title":"Feeding-dependent VIP neuron\u2013ILC3 circuit regulates the intestinal barrier","volume":"579","author":"Talbot","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.111127_bib9","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.18039.1","article-title":"Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system","author":"Iwasaki","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.jbc.2025.111127_bib10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0196-9781(94)90031-0","article-title":"Lymphoid cell subpopulations containing vasoactive intestinal peptide in the rat","volume":"15","author":"Leceta","year":"1994","journal-title":"Peptides (N.Y.)."},{"key":"10.1016\/j.jbc.2025.111127_bib11","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1038\/s41467-022-30041-z","article-title":"A distinctive ligand recognition mechanism by the human vasoactive intestinal polypeptide receptor 2","volume":"13","author":"Xu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.111127_bib12","doi-asserted-by":"crossref","first-page":"7383","DOI":"10.1038\/s41598-019-43717-2","article-title":"Activation of Th lymphocytes alters pattern expression and cellular location of VIP receptors in healthy donors and early arthritis patients","volume":"9","author":"Villanueva-Romero","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2025.111127_bib13","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.4049\/jimmunol.1001829","article-title":"The role of the transcription factor CREB in immune function","volume":"185","author":"Wen","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbc.2025.111127_bib14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.4236\/ijcm.2011.24084","article-title":"Vasoactive Intestinal Peptide (VIP) and VIP receptors-elucidation of structure and function for therapeutic applications","volume":"02","author":"Igarashi","year":"2011","journal-title":"Int. J. Clin. Med."},{"key":"10.1016\/j.jbc.2025.111127_bib15","doi-asserted-by":"crossref","first-page":"31427","DOI":"10.1074\/jbc.273.47.31427","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor \u03b1 transcriptional activation by regulating nuclear Factor-kB and cAMP response element-binding Protein\/c-Jun","volume":"273","author":"Delgado","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.111127_bib16","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1158\/0008-5472.CAN-23-3628","article-title":"VPAC2 receptor signaling promotes growth and immunosuppression in pancreatic cancer","volume":"84","author":"Passang","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2025.111127_bib17","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41598-023-28073-6","article-title":"Vasoactive intestinal peptide blockade suppresses tumor growth by regulating macrophage polarization and function in CT26 tumor-bearing mice","volume":"13","author":"Kittikulsuth","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2025.111127_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0167-0115(02)00195-7","article-title":"In vitro and in vivo treatment of colon cancer by VIP antagonists","volume":"109","author":"Levy","year":"2002","journal-title":"Regul. Pept."},{"key":"10.1016\/j.jbc.2025.111127_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.852358","article-title":"Vasoactive intestinal peptide-VIPR2 signaling regulates tumor cell migration","volume":"12","author":"Asano","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.jbc.2025.111127_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/imed.1033","article-title":"Comparing VIP and PD-L1 expression as cancer biomarkers","author":"Liu","year":"2022","journal-title":"ImmunoMedicine"},{"key":"10.1016\/j.jbc.2025.111127_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1182\/blood-2014-07-591529","article-title":"EVI1-rearranged acute myeloid leukemias are characterized by distinct molecular alterations","volume":"125","author":"Lavall\u00e9e","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2025.111127_bib22","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.3390\/cancers15133284","article-title":"Gene expression analysis links autocrine vasoactive intestinal peptide and ZEB1 in gastrointestinal cancers","volume":"15","author":"Rao","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2025.111127_bib23","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1304336","article-title":"Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemia","volume":"6","author":"Petersen","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jbc.2025.111127_bib24","article-title":"VIPhyb, an antagonist of vasoactive intestinal peptide receptor, enhances cellular antiviral immunity in murine cytomegalovirus infected mice","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2025.111127_bib25","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1182\/blood-2012-06-437640","article-title":"Pharmacological inhibition of VIP signaling enhances antiviral immunity and improves survival in murine cytomegalovirus-infected allogeneic bone marrow transplant recipients","volume":"121","author":"Li","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2025.111127_bib26","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4049\/jimmunol.1100686","article-title":"Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice","volume":"187","author":"Li","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbc.2025.111127_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0022-3565(25)09498-4","article-title":"Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors","volume":"273","author":"Gozes","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jbc.2025.111127_bib28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0006-8993(91)90528-4","article-title":"A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytes","volume":"540","author":"Gozes","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.jbc.2025.111127_bib29","first-page":"3486","article-title":"Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist","volume":"56","author":"Zia","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2025.111127_bib30","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/BF02071131","article-title":"A VIP hybrid antagonist: from developmental neurobiology to clinical applications","volume":"15","author":"Gozes","year":"1995","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.jbc.2025.111127_bib31","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1074\/jbc.273.6.3490","article-title":"Serine 232 and methionine 272 define the ligand binding pocket in retinoic acid receptor subtypes","volume":"273","author":"Ostrowski","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.111127_bib32","doi-asserted-by":"crossref","first-page":"34979","DOI":"10.1074\/jbc.M112.374504","article-title":"The methionine-aromatic motif plays a unique role in stabilizing protein structure","volume":"287","author":"Valley","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.111127_bib33","doi-asserted-by":"crossref","first-page":"8383","DOI":"10.1016\/S0021-9258(18)42456-8","article-title":"Substitution of isoleucine for methionine at position 1153 in the beta-subunit of the human insulin receptor. A mutation that impairs receptor tyrosine kinase activity, receptor endocytosis, and insulin action","volume":"267","author":"Cama","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.111127_bib34","doi-asserted-by":"crossref","first-page":"24003","DOI":"10.1074\/jbc.M002325200","article-title":"Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2Receptors and development of a highly selective VPAC1Receptor agonist","volume":"275","author":"Nicole","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.111127_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048928","article-title":"Design of pH sensitive binding proteins from the hyperthermophilic Sso7d scaffold","volume":"7","author":"Gera","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2025.111127_bib36","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S1367-5931(00)00206-4","article-title":"Combinatorial alanine-scanning","volume":"5","author":"Morrison","year":"2001","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jbc.2025.111127_bib37","first-page":"290","article-title":"Molecular and immunophenotypical characterization of progressive and regressive leukemia cell lines","volume":"20","author":"Hao","year":"2005","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.jbc.2025.111127_bib38","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1158\/0008-5472.CAN-16-0427","article-title":"Modulation of immune checkpoints and graft-versus-leukemia in allogeneic transplants by antagonizing vasoactive intestinal peptide signaling","volume":"76","author":"Li","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2025.111127_bib39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.111127_bib40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pro.3235","article-title":"UCSF ChimeraX: meeting modern challenges in visualization and analysis","volume":"27","author":"Goddard","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.jbc.2025.111127_bib41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"<scp>UCSF ChimeraX<\/scp>: structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.jbc.2025.111127_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"<scp>UCSF ChimeraX<\/scp>: tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci."},{"key":"10.1016\/j.jbc.2025.111127_bib43","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1038\/s41467-022-34629-3","article-title":"Understanding VPAC receptor family peptide binding and selectivity","volume":"13","author":"Piper","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.111127_bib44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41392-024-01803-6","article-title":"G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.jbc.2025.111127_bib45","doi-asserted-by":"crossref","first-page":"14583","DOI":"10.1074\/jbc.M114.560573","article-title":"Therapeutic efficacy of stable analogues of vasoactive intestinal peptide against pathogens","volume":"289","author":"Campos-Salinas","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.111127_bib46","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/jcc.20933","article-title":"The generalized born\/volume integral implicit solvent model: estimation of the free energy of hydration using London dispersion instead of atomic surface area","volume":"29","author":"Labute","year":"2008","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jbc.2025.111127_bib49","series-title":"AMBER 10","author":"Case","year":"2008"},{"key":"10.1016\/j.jbc.2025.111127_bib47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1073\/pnas.2637010100","article-title":"Shifting foci of hematopoiesis during reconstitution from single stem cells","volume":"101","author":"Cao","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.111127_bib48","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.3390\/ijms25084391","article-title":"Chemical modifications to enhance the drug properties of a VIP receptor antagonist (ANT) peptide","volume":"25","author":"Lester","year":"2024","journal-title":"Int. J. Mol. Sci."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825029795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825029795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:59:06Z","timestamp":1777409946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825029795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0021925825029795"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.111127","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and characterization of vasoactive intestinal peptide receptor antagonists with high-affinity and potent anti-leukemia activity","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.111127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"111127"}}